Logo image of CHR

CHEER HOLDING INC-A (CHR) Stock Fundamental Analysis

USA - NASDAQ:CHR - KYG399732042 - Common Stock

0.1207 USD
+0 (+3.16%)
Last: 10/22/2025, 8:22:08 PM
0.124 USD
+0 (+2.73%)
After Hours: 10/22/2025, 8:22:08 PM
Fundamental Rating

4

Taking everything into account, CHR scores 4 out of 10 in our fundamental rating. CHR was compared to 70 industry peers in the Interactive Media & Services industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CHR had positive earnings in the past year.
CHR had a positive operating cash flow in the past year.
Each year in the past 5 years CHR has been profitable.
In the past 5 years CHR always reported a positive cash flow from operatings.
CHR Yearly Net Income VS EBIT VS OCF VS FCFCHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

CHR has a better Return On Assets (7.49%) than 80.00% of its industry peers.
Looking at the Return On Equity, with a value of 8.51%, CHR is in the better half of the industry, outperforming 75.71% of the companies in the same industry.
CHR has a Return On Invested Capital of 6.59%. This is in the better half of the industry: CHR outperforms 75.71% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 13.27%.
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROIC 6.59%
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
CHR Yearly ROA, ROE, ROICCHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

CHR has a better Profit Margin (17.64%) than 84.29% of its industry peers.
CHR's Profit Margin has declined in the last couple of years.
CHR's Operating Margin of 17.39% is amongst the best of the industry. CHR outperforms 84.29% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
CHR has a better Gross Margin (73.24%) than 65.71% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
CHR Yearly Profit, Operating, Gross MarginsCHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHR is still creating some value.
CHR has more shares outstanding than it did 1 year ago.
CHR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CHR is higher compared to a year ago.
CHR Yearly Shares OutstandingCHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CHR Yearly Total Debt VS Total AssetsCHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CHR has an Altman-Z score of 2.47. This is not the best score and indicates that CHR is in the grey zone with still only limited risk for bankruptcy at the moment.
CHR has a better Altman-Z score (2.47) than 68.57% of its industry peers.
CHR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, CHR is doing good in the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.47
ROIC/WACC1.08
WACC6.08%
CHR Yearly LT Debt VS Equity VS FCFCHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CHR has a Current Ratio of 7.66. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
CHR has a better Current ratio (7.66) than 88.57% of its industry peers.
A Quick Ratio of 7.66 indicates that CHR has no problem at all paying its short term obligations.
CHR has a better Quick ratio (7.66) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 7.66
Quick Ratio 7.66
CHR Yearly Current Assets VS Current LiabilitesCHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

CHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.05%.
Measured over the past years, CHR shows a very strong growth in Earnings Per Share. The EPS has been growing by 90.58% on average per year.
CHR shows a decrease in Revenue. In the last year, the revenue decreased by -5.65%.
CHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.28% yearly.
EPS 1Y (TTM)-33.05%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-15.99%
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHR Yearly Revenue VS EstimatesCHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.05 indicates a rather cheap valuation of CHR.
Based on the Price/Earnings ratio, CHR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (27.57), we can say CHR is valued rather cheaply.
Industry RankSector Rank
PE 0.05
Fwd PE N/A
CHR Price Earnings VS Forward Price EarningsCHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.25
CHR Per share dataCHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

CHR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHEER HOLDING INC-A

NASDAQ:CHR (10/22/2025, 8:22:08 PM)

After market: 0.124 +0 (+2.73%)

0.1207

+0 (+3.16%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)07-30 2025-07-30
Earnings (Next)03-09 2026-03-09
Inst Owners19.93%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap2.94M
Revenue(TTM)147.13M
Net Income(TTM)25.97M
Analysts80
Price TargetN/A
Short Float %4.55%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.05
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF 0.13
P/B 0.01
P/tB 0.01
EV/EBITDA -6.25
EPS(TTM)2.32
EY1922.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.94
OCFY779.27%
SpS6.05
BVpS12.54
TBVpS10.87
PEG (NY)N/A
PEG (5Y)0
Graham Number25.59
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROCE 8.34%
ROIC 6.59%
ROICexc 18.54%
ROICexgc 29.52%
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
FCFM N/A
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
ROICexc(3y)21.89%
ROICexc(5y)25.49%
ROICexgc(3y)29.91%
ROICexgc(5y)33.2%
ROCE(3y)11.4%
ROCE(5y)17.04%
ROICexgc growth 3Y-11.82%
ROICexgc growth 5YN/A
ROICexc growth 3Y-18.62%
ROICexc growth 5YN/A
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.05
Cap/Depr 650.5%
Cap/Sales 16.89%
Interest Coverage 78.74
Cash Conversion 77.77%
Profit Quality N/A
Current Ratio 7.66
Quick Ratio 7.66
Altman-Z 2.47
F-Score4
WACC6.08%
ROIC/WACC1.08
Cap/Depr(3y)296.64%
Cap/Depr(5y)223.79%
Cap/Sales(3y)7.33%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.05%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-15.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.6%
EBIT growth 3Y-10.99%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.76%
OCF growth 3Y-21.03%
OCF growth 5YN/A